GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Codon AG (CHIX:CNWKd) » Definitions » Net Income Including Noncontrolling Interests

Codon AG (CHIX:CNWKD) Net Income Including Noncontrolling Interests : €-14.13 Mil (TTM As of Jun. 2022)


View and export this data going back to 2015. Start your Free Trial

What is Codon AG Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Codon AG's Net Income Including Noncontrolling Interests for the six months ended in Jun. 2022 was €-10.99 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Jun. 2022 was €-14.13 Mil.

Codon AG Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Codon AG's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Codon AG Net Income Including Noncontrolling Interests Chart

Codon AG Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Net Income Including Noncontrolling Interests
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.58 -6.27 -12.63 -13.87 -9.32

Codon AG Semi-Annual Data
Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.61 -5.26 -6.19 -3.13 -10.99

Codon AG Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Jun. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-14.13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Codon AG Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Codon AG's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

Codon AG (CHIX:CNWKD) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Codon AG (CHIX:CNWKd) » Definitions » Net Income Including Noncontrolling Interests
Comparable Companies
XTER:T3T1 XTER:PDA XTER:UMDK FRA:TIS STU:QS6A OCSE:NOVO B VRTX REGN ASX:CSL SGEN MRNA XKRX:207940 XBRU:ARGX BNTX HKSE:02269 OCSE:GMAB ALNY BGNE XBRU:UCB BMRN
Traded in Other Exchanges
N/A
Address
Warthestrasse 21, Teltow, DEU, 14513
Website
http://www.codon.de
Codon AG develops, produces and distributes autologous cell therapies for the minimally invasive repair of cartilage defects. The product being marketed is a cell therapy product for the minimally invasive treatment of cartilage damage in the knee joint that uses only the patient's own cartilage cells (autologous chondrocytes). CODON's method is currently used in over 200 clinics in Germany and more than 14,000 patients have already been treated.

Codon AG (CHIX:CNWKD) Headlines

No Headlines